Metacognitive therapy home-based self-help for cardiac rehabilitation patients experiencing anxiety and depressive symptoms: study protocol for a feasibility randomised controlled trial (PATHWAY Home-MCT)

[1]  T. Fergus,et al.  The Metacognitions Questionnaire–30: An Examination of a Bifactor Model and Measurement Invariance Among Men and Women in a Community Sample , 2019, Assessment.

[2]  A. Wells,et al.  Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial , 2018, Trials.

[3]  B. Wampold,et al.  Metacognitive therapy versus disorder-specific CBT for comorbid anxiety disorders: A randomized controlled trial. , 2017, Journal of anxiety disorders.

[4]  E. Watkins,et al.  The association of perseverative negative thinking with depression, anxiety and emotional distress in people with long term conditions: A systematic review. , 2016, Journal of psychosomatic research.

[5]  B. Penninx,et al.  Anxiety and new onset of cardiovascular disease: critical review and meta-analysis , 2016, British Journal of Psychiatry.

[6]  R. V. van Geuns,et al.  Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up , 2016, European journal of preventive cardiology.

[7]  M. Spada,et al.  Thinking about motor fluctuations: An examination of metacognitions in Parkinson's disease. , 2015, Journal of psychosomatic research.

[8]  P. Doherty,et al.  Cardiac rehabilitation , 2015, BMJ : British Medical Journal.

[9]  H. Baumeister,et al.  Inpatient and outpatient costs in patients with coronary artery disease and mental disorders: a systematic review , 2015, BioPsychoSocial Medicine.

[10]  A. Wells,et al.  Metacognitive Therapy Versus Prolonged Exposure in Adults with Chronic Post-traumatic Stress Disorder: A Parallel Randomized Controlled Trial , 2015, Cognitive Therapy and Research.

[11]  H. Baumeister,et al.  The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. , 2014, Journal of psychosomatic research.

[12]  G. Dunn,et al.  A Prospective Study of the Association of Metacognitive Beliefs and Processes with Persistent Emotional Distress After Diagnosis of Cancer , 2014, Cognitive Therapy and Research.

[13]  Peter Johansson,et al.  Depression and cardiovascular disease: a clinical review. , 2014, European heart journal.

[14]  Paul Dendale,et al.  Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery , 2014, European journal of preventive cardiology.

[15]  N. Morina,et al.  THE EFFICACY OF METACOGNITIVE THERAPY FOR ANXIETY AND DEPRESSION: A META‐ANALYTIC REVIEW , 2014, Depression and anxiety.

[16]  D. Rennie,et al.  SPIRIT 2013 statement: defining standard protocol items for clinical trials. , 2013, Annals of internal medicine.

[17]  David Moher,et al.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials , 2013, BMJ.

[18]  C. Gudex,et al.  Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study , 2012, Quality of Life Research.

[19]  M. Spada,et al.  Metacognitive factors in chronic fatigue syndrome. , 2012, Clinical psychology & psychotherapy.

[20]  Martin Knapp,et al.  Long-term conditions and mental health: the cost of co-morbidities , 2012 .

[21]  P. Muris,et al.  Randomized controlled trial on the effectiveness of metacognitive therapy and intolerance-of-uncertainty therapy for generalized anxiety disorder. , 2012, Behaviour research and therapy.

[22]  J. Sharp,et al.  Medical, Psychological, and Sociodemographic Factors Associated With Adherence to Cardiac Rehabilitation Programs: A Systematic Review , 2011, The Journal of cardiovascular nursing.

[23]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[24]  A. Wells,et al.  Metacognitions and negative emotions as predictors of symptom severity in chronic fatigue syndrome. , 2011, Journal of psychosomatic research.

[25]  H. McGee,et al.  Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[26]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, BMC medicine.

[27]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.

[28]  D. Moher,et al.  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.

[29]  Martin J Buxton,et al.  A review of health utilities using the EQ-5D in studies of cardiovascular disease , 2010, Health and quality of life outcomes.

[30]  K. Jolly,et al.  Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[31]  J. Francis,et al.  Comorbid Depression and Anxiety Symptoms as Predictors of Cardiovascular Events: Results From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study , 2009, Psychosomatic medicine.

[32]  Adrian Wells,et al.  Metacognitive Therapy for Anxiety and Depression , 2008 .

[33]  A. Wells,et al.  Measuring metacognitions associated with emotional distress: Factor structure and predictive validity of the metacognitions questionnaire 30 , 2008 .

[34]  G. Lip,et al.  The Birmingham rehabilitation uptake maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation , 2008, Heart.

[35]  A J Mourant,et al.  Home-based versus hospital-based rehabilitation after myocardial infarction: A randomized trial with preference arms--Cornwall Heart Attack Rehabilitation Management Study (CHARMS). , 2007, International journal of cardiology.

[36]  D. Baldwin,et al.  Generalised anxiety disorder , 2006, The Lancet.

[37]  A. Wells,et al.  Distress in Parkinson's disease: contributions of disease factors and metacognitive style. , 2005, The British journal of psychiatry : the journal of mental science.

[38]  C. Herrmann-Lingen,et al.  Depression as a Risk Factor for Mortality in Patients With Coronary Heart Disease: A Meta-analysis , 2004, Psychosomatic medicine.

[39]  P. Williamson,et al.  Design and analysis of pilot studies: recommendations for good practice. , 2004, Journal of evaluation in clinical practice.

[40]  Adrian Wells,et al.  A short form of the metacognitions questionnaire: properties of the MCQ-30. , 2004, Behaviour research and therapy.

[41]  J. Robinson,et al.  A randomised controlled trial of a self-management plan for patients with newly diagnosed angina. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.

[42]  Andrew J. Mackinnon,et al.  Psychometric evaluation of the Hospital Anxiety and Depression Scale (HADS) among female cardiac patients. , 2001, British journal of health psychology.

[43]  D. Bush,et al.  Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. , 2001, The American journal of cardiology.

[44]  G. Devilly,et al.  Psychometric properties of the credibility/expectancy questionnaire. , 2000, Journal of behavior therapy and experimental psychiatry.

[45]  R. Lewin.  Improving quality of life in patients with angina , 1999, Heart.

[46]  A. Gandjour,et al.  Review of Quality-of-Life Evaluations in Patients with Angina Pectoris , 1999, PharmacoEconomics.

[47]  A. Wells,et al.  Modelling cognition in emotional disorder: the S-REF model. , 1996, Behaviour research and therapy.

[48]  N. Black.  CONSORT , 1996, The Lancet.

[49]  N. Frasure-smith,et al.  Depression and 18-month prognosis after myocardial infarction. , 1995, Circulation.

[50]  A. Wells,et al.  Attention and Emotion: A Clinical Perspective , 1994 .

[51]  M. Campbell,et al.  Effects of self-help post-myocardial-infarction rehabilitation on psychological adjustment and use of health services , 1992, The Lancet.

[52]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[53]  M. Hotopf,et al.  Depression and anxiety symptom trajectories in coronary heart disease: Associations with measures of disability and impact on 3-year health care costs. , 2018, Journal of psychosomatic research.

[54]  David Moher,et al.  SPIRIT 2013 Statement: defining standard protocol items for clinical trials. , 2015, Revista panamericana de salud publica = Pan American journal of public health.

[55]  N. Pogosova,et al.  [Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery]. , 2014, Kardiologiia.

[56]  South Dakota,et al.  ANNUAL STATISTICAL REPORT , 2013 .

[57]  Daniel S. Weiss,et al.  The Impact of Event Scale: Revised , 2007 .

[58]  B. Thombs,et al.  Prevalence of depression in survivors of acute myocardial infarction , 2007, Journal of General Internal Medicine.

[59]  A. Dhar,et al.  National Institute for Health and Clinical Excellence , 2005 .

[60]  A. Strauss,et al.  The Discovery of Grounded Theory , 1967 .